Clark Capital Management Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-10,000
| Closed | -$8.7K | – | 370 |
|
|
2016
Q1 | $8.7K | Hold |
10,000
| – | – | ﹤0.01% | 314 |
|
|
2015
Q4 | $12K | Hold |
10,000
| – | – | ﹤0.01% | 300 |
|
|
2015
Q3 | $17K | Sell |
10,000
-2,400
| -19% | -$4.08K | ﹤0.01% | 302 |
|
|
2015
Q2 | $26K | Buy |
12,400
+2,400
| +24% | +$5.03K | ﹤0.01% | 319 |
|
|
2015
Q1 | $27K | Hold |
10,000
| – | – | ﹤0.01% | 312 |
|
|
2014
Q4 | $26K | Hold |
10,000
| – | – | ﹤0.01% | 307 |
|
|
2014
Q3 | $18K | Hold |
10,000
| – | – | ﹤0.01% | 297 |
|
|
2014
Q2 | $27K | Hold |
10,000
| – | – | ﹤0.01% | 319 |
|
|
2014
Q1 | $35K | Hold |
10,000
| – | – | ﹤0.01% | 331 |
|
|
2013
Q4 | $45K | Hold |
10,000
| – | – | ﹤0.01% | 331 |
|
|
2013
Q3 | $41K | Hold |
10,000
| – | – | ﹤0.01% | 334 |
|
|
2013
Q2 | $42K | Buy |
+10,000
| New | +$42K | ﹤0.01% | 323 |
|